B
Bull
Bull · 25%SIMA
$11.61
Precio del escenario
$11.200
+0.224 (+2.00%)Al cierre
Loading chart…
- High
- 11.490
- Open
- 10.850
- VWAP
- 11.18
- Vol
- 3.26K
- Mkt Cap
- —
- Low
- 10.850
- Amount
- 36.41K
- EV/EBITDA, TTM
- 0.00
SIM Acquisition Corp. I is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination target. The Company may pursue an initial business combination in any business or industry, but expects to focus on companies in the healthcare industry. The Company is neither engaged in any operations nor generated any revenues.
AI analysis of SIM Acquisition I Corp (SIMA)
holdCurrently, SIMA is not an attractive buy. The stock is trading at $10.95 with a relatively low RSI of 48.58, indicating it is neither overbought nor oversold. The forward P/E ratio is 0, suggesting a lack of earnings growth expectations, and the price-to-book ratio is high at 16.95, which may indicate overvaluation. Additionally, the stock has shown minimal movement with a 5-day change of only +0.18% and a year-to-date change of +3.60%. The main risk is the current ratio dropping to 0.79, indicating potential liquidity issues in the near future.
Métricas de valoración
The current forward P/E ratio for SIM Acquisition I Corp (SIMA) is 0.00, compared to its 5-year average forward P/E of 0.00.
Alphio AI Price Scenarios for SIMA
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Whales holding SIMA
Cronología de eventos
Noticias
SIMA FAQ — answered by Alphio AI
SIM Acquisition Corp. I is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination target. The Company may pursue an initial business combination in any business or industry, but expects to focus on companies in the healthcare industry. The Company is neither engaged in any operations nor generated any revenues. It operates in the Financials sector.
Currently, SIMA is not an attractive buy. The stock is trading at $10.95 with a relatively low RSI of 48.58, indicating it is neither overbought nor oversold. The forward P/E ratio is 0, suggesting a lack of earnings growth expectations, and the price-to-book ratio is high at 16.95, which may indicate overvaluation. Additionally, the stock has shown minimal movement with a 5-day change of only +0.18% and a year-to-date change of +3.60%. The main risk is the current ratio dropping to 0.79, indicating potential liquidity issues in the near future.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.